文献速递消化道肿瘤与早癌

七个高收入国家2010-2014年结肠癌与直肠癌生存率:按诊断时年龄和分期的差异(ICBP SURVMARK-2项目)

Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
PubMed 文献 · Gut · 2020-06-01

基于七国19个癌症登记处386870例2010-2014年诊断患者的分析显示,结肠癌和直肠癌1年与5年净生存率国家间差异明显,澳大利亚、加拿大和挪威生存率较高且转移性疾病比例较小,区域性和远处转移性结肠癌的生存率国际差异最大,老年和晚期患者生存差异显著。

要点

  • 结肠癌1年净生存率国家间为77.1%至87.5%,直肠癌为84.8%至90.0%。
  • 结肠癌5年净生存率国家间为59.1%至70.9%,直肠癌为61.6%至70.9%。
  • 区域性和远处转移性结肠癌的5年生存率国际差异最大,分别为62.5%至77.5%和8.0%至17.3%。

核心结论

  • 高收入国家间结肠癌和直肠癌生存差异可能由部分国家诊断更早、区域性和远处转移性疾病治疗差异以及诊断时年龄较大解释。
  • 癌症登记实践和分期系统差异可能影响比较。

研究设计与样本

  • 国际癌症基准伙伴关系(ICBP)SURVMARK-2项目,分析七国19个癌症登记处2010-2014年诊断的386870例患者数据。
  • 按诊断时分期、年龄和国家估计结肠癌和直肠癌的1年和5年净生存率。

主要发现

  • 结肠癌1年净生存率国家间为77.1%至87.5%,直肠癌为84.8%至90.0%。
  • 结肠癌5年净生存率国家间为59.1%至70.9%,直肠癌为61.6%至70.9%。
  • 澳大利亚、加拿大和挪威生存率 consistently 较高,加拿大和澳大利亚转移性疾病患者比例较小。
  • 区域性和远处转移性结肠癌的1年净生存率国家间分别为86.0%至94.1%和40.7%至56.4%,5年净生存率分别为62.5%至77.5%和8.0%至17.3%。
  • 直肠癌观察到相似模式;结肠癌和直肠癌的分期分布随年龄和国家而异,转移性疾病和老年诊断患者( irrespective of stage)生存差异显著。

局限性

  • 癌症登记实践差异和各国分期系统不同可能影响比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: As part of the International Cancer Benchmarking Partnership (ICBP) SURVMARK-2 project, we provide the most recent estimates of colon and rectal cancer survival in seven high-income countries by age and stage at diagnosis. METHODS: Data from 386 870 patients diagnosed during 2010-2014 from 19 cancer registries in seven countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway and the UK) were analysed. 1-year and 5-year net survival from colon and rectal cancer were estimated by stage at diagnosis, age and country, RESULTS: (One1-year) and 5-year net survival varied between (77.1% and 87.5%) 59.1% and 70.9% and (84.8% and 90.0%) 61.6% and 70.9% for colon and rectal cancer, respectively. Survival was consistently higher in Australia, Canada and Norway, with smaller proportions of patients with metastatic disease in Canada and Australia. International differences in (1-year) and 5-year survival were most pronounced for regional and distant colon cancer ranging between (86.0% and 94.1%) 62.5% and 77.5% and (40.7% and 56.4%) 8.0% and 17.3%, respectively. Similar patterns were observed for rectal cancer. Stage distribution of colon and rectal cancers by age varied across countries with marked survival differences for patients with metastatic disease and diagnosed at older ages (irrespective of stage). CONCLUSIONS: Survival disparities for colon and rectal cancer across high-income countries are likely explained by earlier diagnosis in some countries and differences in treatment for regional and distant disease, as well as older age at diagnosis. Differences in cancer registration practice and different staging systems across countries may have impacted the comparisons.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Araghi M, Arnold M, Rutherford MJ, et al. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 2020. PMID: 32482683. doi:10.1136/gutjnl-2020-320625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。